Baycrest

This is Baycrest 2024

Baycrest Health Sciences & Baycrest Foundation Publications

Issue link: http://baycrest.uberflip.com/i/1522962

Contents of this Issue

Navigation

Page 4 of 35

5 BAYCREST | 2024 Working together: a story of success and recognition Our donors, our staff, and our extended community all share in our achievements • Baycrest Academy for Research and Education (BARE) includes the internationally recognized cognitive neuroscience centre, Rotman Research Institute, and is led by President and Chief Scientist Dr. Allison Sekuler. Baycrest is the #1 most research-intensive hospital in Canada. Many scientists are ranked by Stanford University among the most highly cited in the world; • Baycrest is the scientific headquarters of the Canadian Consortium on Neurodegeneration in Aging (CCNA), which includes more than 300 leading dementia researchers across Canada. Led by Dr. Howard Chertkow, CCNA is Canada's largest federally funded dementia research program; • The Anne & Allan Bank Centre for Clinical Research Trials at Baycrest has more dementia-related studies of new, emerging therapies than any other site in Canada, from pharmaceuticals to novel interventions such as non- invasive brain stimulation; • Baycrest President & CEO Dr. Bill Reichman co-chaired the Government of Canada's Dementia Advisory Board tasked with developing the nation's dementia strategy; • Care, education, research and innovation come together in a spirit of collaboration and inquiry to create a unique entity that is greater than the sum of its parts. Programs are informed by physicians, scientists, people living with dementia and their caregivers; • Baycrest has a large database of research volunteers, and assessment/data collection tools that are inaccessible to most seniors' facilities: MRI, EEG, MEG and eye-trackers as well as expertise in non-invasive brain stimulation approaches.

Articles in this issue

view archives of Baycrest - This is Baycrest 2024